Can Diane-35 Help Regulate Menstrual Cycles?

Diane-35 (cyproterone acetate and ethinyl estradiol) is a combined oral contraceptive pill approved in many countries for the treatment of severe acne and hirsutism in women of childbearing age. While it is not officially indicated for menstrual regulation, its hormonal composition—specifically the anti-androgenic progestin cyproterone acetate—can lead to more predictable, lighter, and less painful menstrual cycles in some individuals.

By suppressing ovulation and stabilizing endometrial growth, Diane-35 helps reduce menstrual irregularities commonly associated with hyperandrogenic conditions such as polycystic ovary syndrome (PCOS). However, it is important to emphasize that this effect is secondary—not its primary therapeutic purpose—and should not be considered a first-line treatment solely for menstrual dysfunction without an underlying androgen-related indication.

Clinical use requires careful patient selection: Diane-35 is contraindicated in women with a history of venous thromboembolism, cerebrovascular or coronary artery disease, active liver disease, undiagnosed abnormal uterine bleeding, or known or suspected estrogen-dependent malignancies. Routine cardiovascular and hepatic risk assessment is essential before initiation and during ongoing use.

For women seeking menstrual regulation without signs of hyperandrogenism, alternative options—including other combined oral contraceptives, progestin-only methods, or non-hormonal therapies—may be more appropriate and carry a more favorable safety profile. Management should always be individualized, guided by comprehensive clinical evaluation and shared decision-making.